Details of the Drug Formulations

General Information of Drug (ID: DM0QJDC)

Drug Name
Lixisenatide Drug Info
Synonyms Lyxumia (TN)
Indication
Disease Entry ICD 11 Status REF
Type-2 diabetes 5A11 Approved [1]
Cross-matching ID
PubChem CID
90472060
ChEBI ID
CHEBI:85662
CAS Number
320367-13-3
TTD ID
D05MKA
ACDINA ID
D01215

Full List of Drug Formulations Containing This Drug

Lixisenatide 100 mcg/ml Injection
Company Formulation ID FDA Description
Sanofi-Aventis U.S. F24306 Glycerol 85%; Sodium Acetate Trihydrate; Methionine; Metacresol; Water For Injection; Hydrochloric Acid; Sodium Hydroxide
------------------------------------------------------------------------------------
Lixisenatide 50 mcg/ml Injection
Company Formulation ID FDA Description
Sanofi-Aventis U.S. F24391 Glycerol 85%; Sodium Acetate Trihydrate; Methionine; Metacresol; Water For Injection; Hydrochloric Acid; Sodium Hydroxide
------------------------------------------------------------------------------------

References

1 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.